Ching-Liang Ho
- Oncology top 5%
- Pulmonary and Respiratory Medicine top 5%
- Molecular Biology
- Rheumatology top 5%
- Immunology
- Co-authors
- Ayalew TefferiTerra L. LashoTsu-Yi ChaoPan‐Chyr YangJin‐Yuan ShihLecia V. SequistArkadiusz Z. DudekVincent A. Miller
- Topics
- Eosinophilic Disorders and Syndromes (4 papers)Myeloproliferative Neoplasms: Diagnosis and Treatment (4 papers)Chronic Myeloid Leukemia Treatments (3 papers)
- Journals
- BloodPLoS ONEThe Lancet Oncology
- Partner nations
- TaiwanUnited StatesEgypt
In The Last Decade
Ching-Liang Ho
27 papers receiving 907 citations
Peers
Comparison fields: 5 of 75
- Oncology 475
- Pulmonary and Respiratory Medicine 451
- Molecular Biology 251
- Rheumatology 221
- Immunology 140
Countries citing papers authored by Ching-Liang Ho
This map shows the geographic impact of Ching-Liang Ho's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ching-Liang Ho with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ching-Liang Ho more than expected).
Fields of papers citing papers by Ching-Liang Ho
This network shows the impact of papers produced by Ching-Liang Ho. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ching-Liang Ho. The network helps show where Ching-Liang Ho may publish in the future.
Co-authorship network of co-authors of Ching-Liang Ho
This figure shows the co-authorship network connecting the top 25 collaborators of Ching-Liang Ho. A scholar is included among the top collaborators of Ching-Liang Ho based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Ching-Liang Ho. Ching-Liang Ho is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 8 | |
| 2 | 35 | |
| 3 | 16 | |
| 4 | 25 | |
| 5 | 7 | |
| 6 | 1 | |
| 7 | 6 | |
| 8 | 7 | |
| 9 | 8 | |
| 10 | 2 | |
| 11 | 7 | |
| 12 | 1 | |
| 13 | 4 | |
| 14 | 332 | |
| 15 | 32 | |
| 16 | 40 | |
| 17 | 1 | |
| 18 | 25 | |
| 19 | 6 | |
| 20 | 31 |
About Ching-Liang Ho
Ching-Liang Ho is a scholar working on Oncology, Hematology and Genetics, having authored 27 papers that have together received 923 indexed citations. Recurring topics across this work include Eosinophilic Disorders and Syndromes (4 papers), Myeloproliferative Neoplasms: Diagnosis and Treatment (4 papers) and Chronic Myeloid Leukemia Treatments (3 papers). The work is most often cited by research in Oncology (475 citations), Rheumatology (221 citations) and Pulmonary and Respiratory Medicine (451 citations). Ching-Liang Ho has collaborated with scholars based in Taiwan, United States and Egypt. Frequent co-authors include Ayalew Tefferi, Terra L. Lasho, Tsu-Yi Chao, Pan‐Chyr Yang, Jin‐Yuan Shih, Lecia V. Sequist, Arkadiusz Z. Dudek, Vincent A. Miller, Stephanie R. Brockman and Chun-Ming Tsai. Their work appears in journals such as Blood, PLoS ONE and The Lancet Oncology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.